Immune and Long Interspersed Nuclear Element-1 Dysregulation in Schizophrenia: An Exploratory Case-Control Study in a
Carolina Saraiva Nunes de Pinho1, Joel Porfirio Pinto1,2,3, Paulo Levi Bezerra Martins4
1Neuropsychopharmacology and Translational Psychiatry Laboratory, Drug Research and Development Center, Department of Physiology and Pharmacology, Faculty of Medicine, Federal University of Ceará, Fortaleza, CE 60430-275, Brazil.
Background:
Ultra-treatment-resistant schizophrenia (UTRS) is a severe phenotype with unclear biology. Immune dysfunction is increasingly implicated, but the role of retroelements such as long interspersed nuclear element-1 (LINE-1) remains unexplored. We investigated a Brazilian cohort to test whether retrotransposon dysregulation, alongside immune-inflammatory changes, may underlie UTRS.
Study Design:
We evaluated immune-inflammatory and retrotransposon-related biomarkers across schizophrenia subtypes: treatment-sensitive schizophrenia (TSS, n = 18), treatment-resistant schizophrenia (TRS, n = 19), and ultra-treatment-resistant schizophrenia (UTRS, n = 16), compared to healthy controls (n = 23). Participants were recruited from psychiatric outpatient services in Fortaleza, Brazil, and stratified by clinical response to antipsychotic treatment. Biomarkers included cytokines, toll-like receptor 4 (TLR4), and LINE-1 methylation and expression. Data were analyzed using principal component analysis (PCA) and random forest classification.
Study Results:
TLR4 distinguished TRS from TSS and UTRS from non-UTRS (TSS + TRS). Interferon (IFN) gamma and interleukin (IL)-33 differentiated TRS from TSS, while IFN-β emerged as a key marker for UTRS. PCA and random forest identified three biomarker clusters: (1) proinflammatory (IL-1β, IL-6, IL-17, IL-23, IL-33, and MMP-3); (2) treatment-related (TLR4, clozapine exposure, and age at onset); and (3) immunoregulatory (IFN-β and IL-4). Top predictors of UTRS included IFN-β, TLR4, IL-4, IL-17, and MMP-3. LINE-1 analysis revealed increased expression and hypomethylation in UTRS, consistent with epigenetic instability.
Conclusions:
These findings reveal a distinct immune-epigenetic signature associated with treatment resistance in schizophrenia. Immune activation, Th17 signaling, and LINE-1 dysregulation may underlie the UTRS phenotype. Given the limited sample size and post hoc power analysis, the results should be regarded as exploratory and hypothesis-generating, warranting replication in larger cohorts.
More Related Videos
09:09Generating a Reproducible Model of Mid-Gestational Maternal Immune Activation using PolyI:C to Study Susceptibility and Resilience in Offspring
Published on: August 17, 2022
05:14Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra
Published on: September 8, 2021
Related Concept Videos
Non-LTR Retrotransposons
Psychological and Sociocultural Causes of Schizophrenia
Biological Causes of Schizophrenia
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Schizophrenia
